Key points are not available for this paper at this time.
In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival. (Current Controlled Trials number, ISRCTN93793971 controlled-trials.com.).
Building similarity graph...
Analyzing shared references across papers
Loading...
David Cunningham
William Allum
Sally Stenning
New England Journal of Medicine
Medical Research Council
Leiden University Medical Center
Southampton General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Cunningham et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d9b0f45e5bcb4e3b837acb — DOI: https://doi.org/10.1056/nejmoa055531